Current status and prospect of bariatric artery embolization
10.3969/j.issn.1008-794X.2024.08.001
- VernacularTitle:减肥栓塞术现状及展望
- Author:
Qingyue CAO
1
;
Zhi WANG
;
Gaojun TENG
Author Information
1. 210009 江苏南京 东南大学医学院;东南大学附属中大医院介入与血管外科
- Keywords:
bariatric artery embolization;
obesity;
ghrelin;
glucose metabolism
- From:
Journal of Interventional Radiology
2024;33(8):817-820
- CountryChina
- Language:Chinese
-
Abstract:
Over the past 50 years,the global incidence of obesity has dramatically increased,posing a serious threat to human health.Conventional weight loss methods,such as dieting and exercise therapy,are difficult to obtain a stable and rapid weight-loss effect.Besides,most weight-loss drugs available nowadays are not specifically designed for the pure obese population,they are mainly used for diabetes.The prevalence of traditional bariatric surgery is low,and it carries high surgical costs and high risk of developing complications.Therefore,bariatric artery embolization(BAE),regarded as a new weight-loss therapy,has emerged and it has developed rapidly.BAE can not only achieve long-term weight control,but also provide glycemic benefit to patients with pre-diabetes.Compared with traditional bariatric surgery,BAE has the advantages of less trauma,quick recovery and low risk of postoperative complications.However,there is no unified standard for the selection of intraoperative embolization materials and embolization sites so far,and the postoperative changes of gastric function and the specific mechanism of body metabolism improvement need to be further explored.This paper aims to make a detailed review about BAE,focusing on the research background,the technical principles,the latest research progress,and the existing problems.
